Skip to main content
. Author manuscript; available in PMC: 2024 Sep 11.
Published in final edited form as: Diabetes Care. 2022 Nov 1;45(11):2570–2576. doi: 10.2337/dc21-2151

Figure 1—

Figure 1—

Percentage of estimated specific complication costs among total estimated complication costs in Medicare fee-for-service beneficiaries with type 2 diabetes in 2017. “Others” refers to angina, hypoglycemia, blindness and vision loss, retinopathy intravitreal injections, LEA, chronic retinopathy, ketoacidosis, kidney transplant, and photocoagulation; each complication accounted for <5% of the total.